Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Finasteride treats hair loss and reduces prostate cancer risk.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

miR-29 is a key factor that accelerates aging.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Malassezia-associated dermatitis can cause itching in cats with feline paraneoplastic alopecia.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Balding and low testosterone increase risk of urinary stones.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

More research needed to confirm finasteride as standard treatment for FFA.

Sesamin may help treat hair loss by affecting specific cell pathways.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

A rare combination of hair loss and excessive fine hair growth was found in celiac disease patients.

Male pattern baldness does not cause an increased risk of prostate cancer.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

People with alopecia have a higher risk of thyroid cancer.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Dutasteride is a safe and effective treatment for hair loss.

Impaired autophagy may cause hair loss by triggering early catagen.